868 related articles for article (PubMed ID: 27881568)
21. Vitamin D and prognosis in acute myocardial infarction.
Ng LL; Sandhu JK; Squire IB; Davies JE; Jones DJ
Int J Cardiol; 2013 Oct; 168(3):2341-6. PubMed ID: 23415169
[TBL] [Abstract][Full Text] [Related]
22. Sex Differences in Outcomes Following Percutaneous Coronary Intervention According to Age.
Epps KC; Holper EM; Selzer F; Vlachos HA; Gualano SK; Abbott JD; Jacobs AK; Marroquin OC; Naidu SS; Groeneveld PW; Wilensky RL
Circ Cardiovasc Qual Outcomes; 2016 Feb; 9(2 Suppl 1):S16-25. PubMed ID: 26908855
[TBL] [Abstract][Full Text] [Related]
23. Incidence, Characteristics, and Outcomes of Myocardial Infarction in Patients With Peripheral Artery Disease: Insights From the EUCLID Trial.
Olivier CB; Mulder H; Hiatt WR; Jones WS; Fowkes FGR; Rockhold FW; Berger JS; Baumgartner I; Held P; Katona BG; Norgren L; Blomster J; Patel MR; Mahaffey KW
JAMA Cardiol; 2019 Jan; 4(1):7-15. PubMed ID: 30540355
[TBL] [Abstract][Full Text] [Related]
24. First-Ever Ischemic Stroke and Incident Major Adverse Cardiovascular Events in 93 627 Older Women and Men.
Sposato LA; Lam M; Allen B; Shariff SZ; Saposnik G;
Stroke; 2020 Feb; 51(2):387-394. PubMed ID: 31914883
[TBL] [Abstract][Full Text] [Related]
25. Predictors of Coronary Artery Calcium and Long-Term Risks of Death, Myocardial Infarction, and Stroke in Young Adults.
Javaid A; Mitchell JD; Villines TC
J Am Heart Assoc; 2021 Nov; 10(22):e022513. PubMed ID: 34743556
[TBL] [Abstract][Full Text] [Related]
26. Cardiovascular safety for once-weekly dulaglutide in type 2 diabetes: a pre-specified meta-analysis of prospectively adjudicated cardiovascular events.
Ferdinand KC; Botros FT; Atisso CM; Sager PT
Cardiovasc Diabetol; 2016 Feb; 15():38. PubMed ID: 26912057
[TBL] [Abstract][Full Text] [Related]
27. Coronary Artery Ectasia Predicts Future Cardiac Events in Patients With Acute Myocardial Infarction.
Doi T; Kataoka Y; Noguchi T; Shibata T; Nakashima T; Kawakami S; Nakao K; Fujino M; Nagai T; Kanaya T; Tahara Y; Asaumi Y; Tsuda E; Nakai M; Nishimura K; Anzai T; Kusano K; Shimokawa H; Goto Y; Yasuda S
Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2350-2355. PubMed ID: 29051141
[TBL] [Abstract][Full Text] [Related]
28. Atherothrombotic Risk Stratification and the Efficacy and Safety of Vorapaxar in Patients With Stable Ischemic Heart Disease and Previous Myocardial Infarction.
Bohula EA; Bonaca MP; Braunwald E; Aylward PE; Corbalan R; De Ferrari GM; He P; Lewis BS; Merlini PA; Murphy SA; Sabatine MS; Scirica BM; Morrow DA
Circulation; 2016 Jul; 134(4):304-13. PubMed ID: 27440003
[TBL] [Abstract][Full Text] [Related]
29. Type 2 myocardial infarction: incidence, presentation, treatment and outcome in routine clinical practice.
Radovanovic D; Pilgrim T; Seifert B; Urban P; Pedrazzini G; Erne P
J Cardiovasc Med (Hagerstown); 2017 May; 18(5):341-347. PubMed ID: 28107211
[TBL] [Abstract][Full Text] [Related]
30. Effects of Liraglutide on Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus With or Without History of Myocardial Infarction or Stroke.
Verma S; Poulter NR; Bhatt DL; Bain SC; Buse JB; Leiter LA; Nauck MA; Pratley RE; Zinman B; Ørsted DD; Monk Fries T; Rasmussen S; Marso SP
Circulation; 2018 Dec; 138(25):2884-2894. PubMed ID: 30566004
[TBL] [Abstract][Full Text] [Related]
31. Association of β-blocker therapy with risks of adverse cardiovascular events and deaths in patients with ischemic heart disease undergoing noncardiac surgery: a Danish nationwide cohort study.
Andersson C; Mérie C; Jørgensen M; Gislason GH; Torp-Pedersen C; Overgaard C; Køber L; Jensen PF; Hlatky MA
JAMA Intern Med; 2014 Mar; 174(3):336-44. PubMed ID: 24247428
[TBL] [Abstract][Full Text] [Related]
32. Morbidity and cause-specific mortality in first-time myocardial infarction with nonobstructive coronary arteries.
Eggers KM; Hjort M; Baron T; Jernberg T; Nordenskjöld AM; Tornvall P; Lindahl B
J Intern Med; 2019 Apr; 285(4):419-428. PubMed ID: 30474313
[TBL] [Abstract][Full Text] [Related]
33. Comparison of one-year outcome of patients aged <75 years versus ≥75 years undergoing "rescue" percutaneous coronary intervention.
De Felice F; Fiorilli R; Parma A; Musto C; Nazzaro MS; Confessore P; Scappaticci M; Cifarelli A; Violini R
Am J Cardiol; 2011 Oct; 108(8):1075-80. PubMed ID: 21791331
[TBL] [Abstract][Full Text] [Related]
34. Effect of Definition on Incidence and Prognosis of Type 2 Myocardial Infarction.
Nestelberger T; Boeddinghaus J; Badertscher P; Twerenbold R; Wildi K; Breitenbücher D; Sabti Z; Puelacher C; Rubini Giménez M; Kozhuharov N; Strebel I; Sazgary L; Schneider D; Jann J; du Fay de Lavallaz J; Miró Ò; Martin-Sanchez FJ; Morawiec B; Kawecki D; Muzyk P; Keller DI; Geigy N; Osswald S; Reichlin T; Mueller C;
J Am Coll Cardiol; 2017 Sep; 70(13):1558-1568. PubMed ID: 28935032
[TBL] [Abstract][Full Text] [Related]
35. N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease.
Kragelund C; Grønning B; Køber L; Hildebrandt P; Steffensen R
N Engl J Med; 2005 Feb; 352(7):666-75. PubMed ID: 15716560
[TBL] [Abstract][Full Text] [Related]
36. Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial.
Aguilar D; Solomon SD; Køber L; Rouleau JL; Skali H; McMurray JJ; Francis GS; Henis M; O'Connor CM; Diaz R; Belenkov YN; Varshavsky S; Leimberger JD; Velazquez EJ; Califf RM; Pfeffer MA
Circulation; 2004 Sep; 110(12):1572-8. PubMed ID: 15364810
[TBL] [Abstract][Full Text] [Related]
37. Acute versus chronic myocardial injury and long-term outcomes.
Kadesjö E; Roos A; Siddiqui A; Desta L; Lundbäck M; Holzmann MJ
Heart; 2019 Dec; 105(24):1905-1912. PubMed ID: 31337668
[TBL] [Abstract][Full Text] [Related]
38. Cerebrovascular events after a primary percutaneous coronary intervention strategy for acute ST-segment-elevation myocardial infarction: analysis from the HORIZONS-AMI Trial.
Nikolsky E; Mehran R; Dangas GD; Xu K; Parvataneni R; Witzenbichler B; Guagliumi G; Kornowski R; Généreux P; Brener SJ; Stone GW
Circ Cardiovasc Interv; 2015 Apr; 8(4):. PubMed ID: 25858976
[TBL] [Abstract][Full Text] [Related]
39. Nonobstructive coronary artery disease and risk of myocardial infarction.
Maddox TM; Stanislawski MA; Grunwald GK; Bradley SM; Ho PM; Tsai TT; Patel MR; Sandhu A; Valle J; Magid DJ; Leon B; Bhatt DL; Fihn SD; Rumsfeld JS
JAMA; 2014 Nov; 312(17):1754-63. PubMed ID: 25369489
[TBL] [Abstract][Full Text] [Related]
40. The appropriateness of coronary investigation in myocardial injury and type 2 myocardial infarction (ACT-2): A randomized trial design.
Lambrakis K; French JK; Scott IA; Briffa T; Brieger D; Farkouh ME; White H; Chuang AM; Tiver K; Quinn S; Kaambwa B; Horsfall M; Morton E; Chew DP
Am Heart J; 2019 Feb; 208():11-20. PubMed ID: 30522086
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
